Effects of opioid blockade with nalmefene in older impotent men.

[1]  S. S. Davis,et al.  Impotence and Aging: Clinical and Hormonal Factors , 1988, Journal of the American Geriatrics Society.

[2]  J. Morley.  Neuropeptide regulation of appetite and weight. , 1987, Endocrine reviews.

[3]  B. Hatfield,et al.  Serum beta-endorphin and affective responses to graded exercise in young and elderly men. , 1987, Journal of gerontology.

[4]  D. Hatsukami,et al.  High-dose naltrexone therapy and dietary counseling for obesity , 1987, Biological Psychiatry.

[5]  D. Kaiser,et al.  Effects of long‐term therapy with naltrexone on body weight in obesity , 1985, Clinical pharmacology and therapeutics.

[6]  J. Vasselli,et al.  Naltrexone and human eating behavior: A dose-ranging inpatient trial in moderately obese men , 1985, Brain Research Bulletin.

[7]  M. Kavaliers,et al.  The influence of opiate agonists on day-night feeding rhythms in young and old mice , 1985, Brain Research.

[8]  E. Nieschlag,et al.  Effect of different doses of naloxone on serum levels of prolactin and gonadotropins in young male volunteers , 1985, Journal of endocrinological investigation.

[9]  G. Casale,et al.  Beta-endorphin and cold pressor test in the aged. , 1985, Gerontology.

[10]  P. O'Neil,et al.  A controlled trial of naltrexone in obese humans. , 1985, International journal of obesity.

[11]  B. Baranowska,et al.  The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion. , 1984, The Journal of clinical endocrinology and metabolism.

[12]  G. Federspil,et al.  Effects of naloxone on gonadotropin secretion in castrated young males before and after testosterone treatment. , 1983, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[13]  J. Liu,et al.  Endogenous opioid regulation of gonadotropin-releasing hormone release from the human fetal hypothalamus in vitro. , 1983, The Journal of clinical endocrinology and metabolism.

[14]  J. Morley,et al.  Involvement of dynorphin and the kappa opioid receptor in feeding , 1983, Peptides.

[15]  F. Petraglia,et al.  Different patterns of central and peripheral βEP, βLPH and ACTH throughout life , 1983, Peptides.

[16]  J. Morley,et al.  The effects of aging on opioid modulation of feeding in rats. , 1983, Life sciences.

[17]  J. Morley,et al.  Opioid modulation of appetite , 1983, Neuroscience & Biobehavioral Reviews.

[18]  F. Nuttall,et al.  Impotence in medical clinic outpatients. , 1983, JAMA.

[19]  R. Atkinson.  Naloxone decreases food intake in obese humans. , 1982, The Journal of clinical endocrinology and metabolism.

[20]  J. D. McGaugh,et al.  Alterations in Dihydromorphine Binding in Cerebral Hemispheres of Aged Male Rats , 1981, Journal of neurochemistry.

[21]  S. Gambert,et al.  Age-related changes in central nervous system beta-endorphin and ACTH. , 1980, Neuroendocrinology.

[22]  K. Jamison,et al.  Endocrine effects of naloxone-induced opiate receptor blockade. , 1980, The Journal of clinical endocrinology and metabolism.

[23]  J. Volavka,et al.  Naloxone increases ACTH and cortisol levels in man. , 1979, The New England journal of medicine.

[24]  T. Cicero,et al.  Endogenous opioids participate in the regulation of the hypothalamus-pituitary-luteinizing hormone axis and testosterone's negative feedback control of luteinizing hormone. , 1979, Endocrinology.

[25]  A. Panerai,et al.  Opioid peptides modulate luteinizing hormone secretion during sexual maturation. , 1979, Science.

[26]  P. Snyder,et al.  Serum LH and FSH responses to synthetic gonadotropin-releasing hormone in normal men. , 1975, The Journal of clinical endocrinology and metabolism.

[27]  J. Fishman,et al.  Narcotic antagonists. 4. Carbon-6 derivatives of N-substituted noroxymorphones as narcotic antagonists. , 1975, Journal of medicinal chemistry.